Effects of a community-based weight loss intervention on adipose tissue circulating factors

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 8, Issue 4, 2014, Pages 205-211

  Miller, Gary D ^a   Isom, Scott ^b   Morgan, Timothy M ^b   Vitolins, Mara Z ^b   Blackwell, Caroline ^b   Brosnihan, K Bridget ^b   Diz, Debra I ^b   Katula, Jeff ^a   Goff, David ^c  

^a WAKE FOREST UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Global Health and Health Disparities   (United States)

Author keywords

Adipose tissue; Diabetes; Metabolic syndrome; Obesity; Prediabetes; Weight loss

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; SERPINE1 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; ADULT; ANALYSIS OF COVARIANCE; ARTICLE; CARDIOVASCULAR RISK; EATING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; METABOLIC DISORDER; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; CONTROLLED STUDY; EXERCISE; FEMALE; HEALTH CENTER; INFLAMMATION; INSULIN RESISTANCE; LOW CALORY DIET; MALE; METABOLISM; MIDDLE AGED; PREDIABETIC STATE; TREATMENT OUTCOME; WEIGHT LOSS PROGRAM;

ADIPONECTIN; ADIPOSE TISSUE; BIOMARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH CENTERS; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDIABETIC STATE; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT REDUCTION PROGRAMS;

EID: 84916603703     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.09.003     Document Type: Article

References (54)

1. N. Ouchi, S. Kihara, T. Funahashi, Y. Matsuzawa, and K. Walsh Obesity, adiponectin and vascular inflammatory disease Curr Opin Lipidol 14 2003 561 566
2. A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ Res 96 2005 939 949
3. N. Ouchi, J.L. Parker, J.J. Lugus, and K. Walsh Adipokines in inflammation and metabolic disease Nat Rev Immunol 11 2011 85 97
4. S.E. Wozniak, L.L. Gee, M.S. Wachtel, and E.E. Frezza Adipose tissue: the new endocrine organ?. A review article Dig Dis Sci 54 2009 1847 1856
5. N. Halberg, I. Wernstedt-Asterholm, and P.E. Scherer The adipocyte as an endocrine cell Endocrinol Metab Clin North Am 37 2008 753 768 x-xi
6. S. Lehr, S. Hartwig, and H. Sell Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders Proteomics Clin Appl 6 2012 91 101
7. J. Van de Voorde, B. Pauwels, C. Boydens, and K. Decaluwe Adipocytokines in relation to cardiovascular disease Metabolism 62 2013 1513 1521
8. S.M. Grundy Approach to lipoprotein management in 2001 National Cholesterol Guidelines Am J Cardiol 90 2002 11i 21i
9. E.J. Gallagher, D. Leroith, and E. Karnieli Insulin resistance in obesity as the underlying cause for the metabolic syndrome Mt Sinai J Med 77 2010 511 523
10. E.S. Ford Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 2005 1769 1778
11. S. Malik, N.D. Wong, S.S. Franklin, T.V. Kamath, G.J. L'Italien, and J.R. Pio Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults Circulation 110 2004 1245 1250
12. C.J. Girman, T. Rhodes, M. Mercuri, K. Pyorala, J. Kjekshus, and T.R. Pedersen The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Am J Cardiol 93 2004 136 141
13. A. Scuteri, S.S. Najjar, C.H. Morrell, and E.G. Lakatta The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study Diabetes Care 28 2005 882 887
14. F.B. Hu, J.B. Meigs, T.Y. Li, N. Rifai, and J.E. Manson Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 53 2004 693 700
15. E. Bonora, G. Targher, G. Formentini, F. Calcaterra, S. Lombardi, and F. Marini The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study Diabet Med 21 2004 52 58
16. H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, and J. Tuomilehto The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
17. M.P. Stern, K. Williams, C. Gonzalez-Villalpando, K.J. Hunt, and S.M. Haffner Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27 2004 2676 2681
18. R.B. Ervin Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006 Natl Health Stat Rep 2009 1 7
19. H.M. Siragy Comparing angiotensin II receptor blockers on benefits beyond blood pressure Adv Ther 27 2010 257 284
20. J. Alfie, L.S. Aparicio, and G.D. Waisman Current strategies to achieve further cardiac and renal protection through enhanced renin-angiotensin-aldosterone system inhibition Rev Recent Clin Trials 6 2011 134 146
21. S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, and B.A. Franklin Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2005 2735 2752
22. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, and E.A. Walker Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
23. J. Tuomilehto, J. Lindstrom, J.G. Eriksson, T.T. Valle, H. Hamalainen, and P. Ilanne-Parikka Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 2001 1343 1350
24. S. Haffner, M. Temprosa, J. Crandall, S. Fowler, R. Goldberg, and E. Horton Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance Diabetes 54 2005 1566 1572
25. C. Herder, M. Peltonen, W. Koenig, K. Sutfels, J. Lindstrom, and S. Martin Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study Diabetologia 52 2009 433 442
26. J.A. Katula, M.Z. Vitolins, E.L. Rosenberger, C. Blackwell, M.A. Espeland, and M.S. Lawlor Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods Contemp Clin Trials 31 2010 71 81
27. J.A. Katula, M.Z. Vitolins, E.L. Rosenberger, C.S. Blackwell, T.M. Morgan, and M.S. Lawlor One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project Diabetes Care 34 2011 1451 1457
28. J.A. Katula, M.Z. Vitolins, T.M. Morgan, M.S. Lawlor, C.S. Blackwell, and S.P. Isom The Healthy Living Partnerships to Prevent Diabetes study: 2-year outcomes of a randomized controlled trial Am J Prev Med 44 2013 S324 S332
29. K. van der Kooy, and J.C. Seidell Techniques for the measurement of visceral fat: a practical guide Int J Obes Relat Metab Disord 17 1993 187 196
30. Diagnosis and classification of diabetes mellitus Diabetes Care 27 Suppl. 1 2004 S5 S10
31. M.F. Linton, and S. Fazio A practical approach to risk assessment to prevent coronary artery disease and its complications Am J Cardiol 92 2003 19i 26i
32. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel, III) JAMA 285 2001 2486 2497
33. S.B. Biddinger, and C.R. Kahn From mice to men: insights into the insulin resistance syndromes Annu Rev Physiol 68 2006 123 158
34. M.K. Ali, J. Echouffo-Tcheugui, and D.F. Williamson How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood) 31 2012 67 75
35. J. Lee Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes Arch Pharm Res 36 2013 208 222
36. S.E. Shoelson, L. Herrero, and A. Naaz Obesity, inflammation, and insulin resistance Gastroenterology 132 2007 2169 2180
37. J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823
38. B.B. Duncan, M.I. Schmidt, J.S. Pankow, C.M. Ballantyne, D. Couper, and A. Vigo Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 52 2003 1799 1805
39. H. Shi, M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier TLR4 links innate immunity and fatty acid-induced insulin resistance J Clin Investig 116 2006 3015 3025
40. B.A. Bhatt, J.J. Dube, N. Dedousis, J.A. Reider, and R.M. O'Doherty Diet-induced obesity and acute hyperlipidemia reduce IkappaBalpha levels in rat skeletal muscle in a fiber-type dependent manner Am J Physiol Regul Integr Comp Physiol 290 2006 R233 R240
41. D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, and J. Lee Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat Med 11 2005 183 190
42. R. Cancello, C. Henegar, N. Viguerie, S. Taleb, C. Poitou, and C. Rouault Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 54 2005 2277 2286
43. G.B. Di Gregorio, A. Yao-Borengasser, N. Rasouli, V. Varma, T. Lu, and L.M. Miles Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone Diabetes 54 2005 2305 2313
44. J. Aron-Wisnewsky, J. Tordjman, C. Poitou, F. Darakhshan, D. Hugol, and A. Basdevant Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss J Clin Endocrinol Metab 94 2009 4619 4623
45. K. Clement, N. Viguerie, C. Poitou, C. Carette, V. Pelloux, and C.A. Curat Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects FASEB J 18 2004 1657 1669
46. A. Festa, K. Williams, R.P. Tracy, L.E. Wagenknecht, and S.M. Haffner Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes Circulation 113 2006 1753 1759
47. J.M. Tishinsky, D.J. Dyck, and L.E. Robinson Lifestyle factors increasing adiponectin synthesis and secretion Vitam Horm 90 2012 1 30
48. K.M. Beavers, W.T. Ambrosius, B.J. Nicklas, and W.J. Rejeski Independent and combined effects of physical activity and weight loss on inflammatory biomarkers in overweight and obese older adults J Am Geriatr Soc 61 2013 1089 1094
49. S.P. Messier, S.L. Mihalko, C. Legault, G.D. Miller, B.J. Nicklas, and P. DeVita Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial JAMA 310 2013 1263 1273
50. I. Imayama, C.M. Ulrich, C.M. Alfano, C. Wang, L. Xiao, and M.H. Wener Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial Cancer Res 72 2012 2314 2326
51. J.S. Chae, J.K. Paik, R. Kang, M. Kim, Y. Choi, and S.H. Lee Mild weight loss reduces inflammatory cytokines, leukocyte count, and oxidative stress in overweight and moderately obese participants treated for 3 years with dietary modification Nutr Res 33 2013 195 203
52. F. Illan-Gomez, M. Gonzalvez-Ortega, I. Orea-Soler, M.S. Alcaraz-Tafalla, A. Aragon-Alonso, and M. Pascual-Diaz Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery Obes Surg 22 2012 950 955
53. H.P. Kopp, K. Krzyzanowska, M. Mohlig, J. Spranger, A.F. Pfeiffer, and G. Schernthaner Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women Int J Obes (Lond) 29 2005 766 771
54. S. Appachi, and S.R. Kashyap 'Adiposopathy' and cardiovascular disease: the benefits of bariatric surgery Curr Opin Cardiol 28 2013 540 546